ENG/中
老虎證券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物科技指數ETF-iShares Nasdaq
199.54
-4.1800
-2.05%
盤後:
200.90
1.36
+0.68%
19:59 EST
成交量:
259.09萬
成交額:
5.24億
市值:
106.16億
市盈率:
31.61
高:
205.99
開:
203.93
低:
199.26
收:
203.72
52周最高:
222.29
52周最低:
159.68
股本:
5,320.00萬
流通股本:
5,320.00萬
量比:
1.40
換手率:
4.87%
股息:
0.35
股息率:
0.17%
每股收益(TTM):
6.31
每股收益(LYR):
35.34
淨資產收益率:
24.54%
總資產收益率:
0.10%
市淨率:
1.30
市盈率(LYR):
5.65
資料載入中...
總覽
公司
新聞資訊
公告
生物類似藥集採迎進展:11月24號開始信息申報,涉及7個品種15個規格
澎湃新闻
·
昨天
Piper Sandler上調安進目標價至542美元
格隆汇
·
11/20
再生元(REGN)聯合Alnylam(ALNY)RNA療法Livsayis獲FDA批准
金吾财讯
·
11/19
美國研究綜述-Aecom、Anthropic、戰略
路透中文
·
11/19
更正-更新版 2-美國食品藥品監督管理局(FDA)批准Regeneron公司用於治療全身性重症肌無力的藥物(11月18日)
路透中文
·
11/19
更正-更新版 2-美國食品藥品監督管理局(FDA)批准Regeneron公司用於治療全身性重症肌無力的藥物(11月18日)
路透中文
·
11/19
美國食品藥品監督管理局批准賽諾菲的一款遺傳性疾病藥物
路透中文
·
11/19
Biocon的帕妥珠單抗獲歐盟上市許可,成為EMA新「定製化臨床方法」下首個獲批的生物類似藥。
智通财经
·
11/18
一年多兩度終止,亞寶藥業創新藥研發頻遇挫
东方财富网
·
11/18
Genomics Ltd.宣佈延長與福泰製藥的戰略藥物發現合作
美股速递
·
11/18
吉利德科學:首席企業事務官Johanna Mercier行權並減持2.8萬股,套現約477.55萬美元
南方财经网
·
11/18
再生元製藥:Libtayo新給藥方案獲批,初始12周每3周350毫克後改為每6周700毫克
美股速递
·
11/17
再生元製藥:Libtayo給藥方案補充生物製品許可申請在美接受審查,預計2027年3月獲批
美股速递
·
11/17
Libtayo®(西米普利單抗)獲歐盟批准:皮膚癌、肺癌及宮頸癌適應症可實現延長給藥與更快輸注
美股速递
·
11/17
巴克萊上調安進目標價至430美元
格隆汇
·
11/17
吉利德就一款試驗性埃博拉藥物簽署了仿製藥許可協議
路透中文
·
11/17
吉利德:相關協議覆蓋127箇中低收入國家,涵蓋所有出現埃博拉病毒病例的非洲國家
美股速递
·
11/17
吉利德科學攜手Dr. Reddy’s、Eva Pharma及Ferozsons Laboratories達成自願許可協議
美股速递
·
11/17
吉利德科學通過自願許可擴大在研藥物Obeldesivir用於本迪布焦型埃博拉病毒病的可及性
美股速递
·
11/17
英硅智能(03696.HK)與羅欣藥業(002793.SZ)達成 AI 製藥戰略合作,聚焦消化與代謝等慢性病創新藥研發
智通财经
·
11/13
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/IBB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":199.54,"timestamp":1795208400000,"preClose":203.72,"halted":0,"volume":2590873,"hourTrading":{"tag":"盘后","latestPrice":200.9,"preClose":199.54,"latestTime":"19:59 EST","volume":25359,"amount":5065611.0972,"timestamp":1795222747886,"change":1.36,"changeRate":0.006816,"amplitude":0.007317},"delay":0,"changeRate":-0.02051835853131753,"floatShares":53200000,"shares":53200000,"eps":6.311863,"marketStatus":"休市中","change":-4.18,"latestTime":"11-20 16:00:00 EST","open":203.925,"high":205.99,"low":199.26,"amount":523803789.7671,"amplitude":0.033036,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1795424400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":203.72,"sharesOutstanding":49450000,"nav":203.6628,"aum":10733029560,"dividendRate":0.001735,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":203.62,"preClose":203.72,"latestTime":"09:29 EST","volume":1025,"amount":208284.59199999998,"timestamp":1795184999999,"change":-0.1,"changeRate":-0.000491,"amplitude":0.011347},"postHourTrading":{"tag":"盘后","latestPrice":200.9,"preClose":199.54,"latestTime":"19:59 EST","volume":25359,"amount":5065611.0972,"timestamp":1795222747886,"change":1.36,"changeRate":0.006816,"amplitude":0.007317},"volumeRatio":1.3958627248686988,"impliedVol":0.3206,"impliedVolPercentile":0.992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":53200000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":1.3958627248686988,"shares":53200000,"dividePrice":0.3463,"high":205.99,"amplitude":0.033036,"preClose":203.72,"low":199.26,"week52Low":159.68,"pbRate":"1.30","psRate":"255.40","week52High":222.29,"institutionHeld":0,"latestPrice":199.54,"eps":6.311863,"divideRate":0.001735,"volume":2590873,"delay":0,"ttmEps":6.311863,"open":203.925,"prevYearClose":168.77,"prevWeekClose":212.5,"prevMonthClose":217.61,"prevQuarterClose":210.53,"fiveDayClose":212.5,"twentyDayClose":207.74,"sixtyDayClose":214.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2685197179","title":"生物類似藥集採迎進展:11月24號開始信息申報,涉及7個品種15個規格","url":"https://stock-news.laohu8.com/highlight/detail?id=2685197179","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2685197179?lang=zh_tw&edition=fundamental","pubTime":"2026-11-21 20:18","pubTimestamp":1795263502,"startTime":"0","endTime":"0","summary":"时隔一年多,生物类似药集采再次迎来重要进展!11月21日,安徽省医药集中采购平台发布《全国药品联盟集中带量采购(单克隆抗体类)公告(第1号)》。各省、自治区、直辖市及新疆生产建设兵团组成全国单抗类制剂联盟采购办公室,代表各地区公立、军队医疗机构,以及社会办医药机构等,开展全国药品联盟集中带量采购(单克隆抗体类),由安徽省医疗保障局承担日常工作并具体实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611213936841431.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611213936841431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","IBB","LU2322448791.USD","LU2473716301.USD","XPH","LU2272731865.HKD","IE00B5TLWC47.USD","BK4588","LU2322448957.HKD","LU2272731600.USD","PPH","LU1992135399.USD","LU1992135472.HKD","LU2272731782.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684132527","title":"Piper Sandler上調安進目標價至542美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684132527","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684132527?lang=zh_tw&edition=fundamental","pubTime":"2026-11-20 16:50","pubTimestamp":1795164624,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0320765992.SGD","LU0058720904.USD","BK4533","IBBQ","IE00BJJMRZ35.SGD","PBE","LU1057294990.SGD","TBXU","LU1983299246.USD","LU0109394709.USD","LU0289739699.SGD","IE0002141913.USD","BK4139","BK4599","AMGN","LU1061106388.HKD","LU1023059063.AUD","BK4588","LU1571399168.USD","IE0009355771.USD","IBB","LU2242646821.SGD","UDN","BBH","LU2112291526.USD","BK4585","LU2089984988.USD","BK4566","IE00BJT1NW94.SGD","BIB","LU0122379950.USD","LU1236620750.USD","BK4534","SG9999001440.SGD","UUP","IE00B4R5TH58.HKD","LU0868494617.USD","LU2242652126.USD","LU2468319806.SGD","PJP","LU0889565916.HKD","LU1236620834.HKD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684979780","title":"再生元(REGN)聯合Alnylam(ALNY)RNA療法Livsayis獲FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2684979780","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684979780?lang=zh_tw&edition=fundamental","pubTime":"2026-11-19 20:46","pubTimestamp":1795092383,"startTime":"0","endTime":"0","summary":"今年早些时候,FDA对cemdesiran新药申请授予优先审评资格,目标审评日期定于11月。根据双方全球许可协议,再生元负责生产和商业化这款注射药物。该新药申请依托3期NIMBLE试验数据支持,cemdesiran作为单药疗法,在有症状成人gMG患者中达到主要终点。Livsayis是首个也是唯一获批治疗gMG的siRNA疗法,同时也是再生元首款该类疗法。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"308567","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","BK4588","LU2089984988.USD","TBXU","LU2468319806.SGD","BK4548","LU0823416689.USD","LU2023250504.SGD","LABU","LU0320765992.SGD","LU2324357040.USD","LU0823434583.USD","LU2362541273.HKD","LU0053666078.USD","BK4585","REGN","LU0109394709.USD","LU1917777945.USD","GNMX","LU0823434740.USD","LU0058720904.USD","LU2362541513.USD","LU0289739699.SGD","IBBQ","PBE","LU2106854487.HKD","ALNY","BK4139","LU0882574055.USD","LU1974910355.USD","LU0889565916.HKD","LU2362540622.SGD","LU2237438978.USD","LU0114720955.EUR","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684259139","title":"美國研究綜述-Aecom、Anthropic、戰略","url":"https://stock-news.laohu8.com/highlight/detail?id=2684259139","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684259139?lang=zh_tw&edition=fundamental","pubTime":"2026-11-19 15:48","pubTimestamp":1795074527,"startTime":"0","endTime":"0","summary":"美国研究综述-Aecom、Anthropic、战略路透社11月19日-周四,华尔街证券分析师下调了多家在美国上市公司的评级和目标股价,其中包括Aecom、Anthropic和Strategy。要点* AecomACM.N:RBC将目标价从89美元上调至102美元* Anthropic, PbcANT.O:Needham首次覆盖,给予“买入”评级;目标价150美元* StrategyMSTR.O:Monness Crespi Hardt将评级从“中性”下调至“卖出”以下是路透社周四报导的针对美国公司的研究行动摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261119:nL3T4700OE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861219969.SGD","IE00BLDYK493.USD","LU2308191902.HKD","LU0211328371.USD","LU1623119135.USD","LU2023251221.USD","BK4600","BK4127","BK4524","CI","LU0187121727.USD","LU1894683348.USD","ROK","LU1064131342.USD","BK4083","04332","LU2237443382.USD","LU1169589451.USD","BK4533","LNG","MSTC","LU2298064838.USD","LNGX","LU1674673428.USD","LU1791807156.HKD","LU0868494617.USD","IE00BMPRXN33.USD","IE00B29SXL02.USD","PYPY","IE00BFTCPJ56.SGD","LU1778281490.HKD","AMGN","LU1244550494.USD","LU2355687059.USD","BK4187","PYPG","LU0942090050.USD","SMST","IMST","LU0251142724.SGD","LU1989764664.SGD","LU1720051017.SGD","LU1988902786.USD","IE00B19Z8X17.USD","TGT","LU1804176565.USD","TNGY","LU1621767810.EUR","LU1059921491.USD","IE00BMG7P926.USD","BK4585","LU1939255532.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","MSTK","BK4534","07399","LU2362540622.SGD","LU0630314457.HKD","SG9999014039.USD","MSTY","SG9999001424.SGD","IE00B19Z3B42.SGD","LU1720051108.HKD","BK4106","LU0348723411.USD","EXP","LU2210149790.SGD","PXI","LU0823411888.USD","SPAM","BK4183","LU2095319765.USD","LU0472753341.HKD","LU0368265418.SGD","LU0124676726.USD","BK4551","BK4532","LU2237443549.SGD","LU0314106906.USD","PYPU","LU1935042488.USD","IE00BMG7P694.USD","LU0390134368.USD","IE00B2B36J28.USD","BK4023","LU1923622291.USD","LU2449327464.USD","LU0251131958.USD","IE00BYQQ9H92.USD","IE00BZ18W456.USD","LU0310800965.SGD","LU2065731478.USD","MSII","LU2360107325.USD","BUG","PANG","07799","MTYY","LU1668664300.SGD","MSST","MSOO","LU1621768115.EUR","LU0963586101.USD","LU2264538146.SGD","LU2468319806.SGD","SG9999014005.SGD","LU1267930490.SGD","BK4599","LU2362541513.USD","IE00BQXX3C00.GBP","LU1267930227.SGD","ANT","LU0868494708.USD","SG9999014013.SGD","LU1861215975.USD","IE0009355771.USD","BESF","PALD","LU0054578231.USD","IE0002141913.USD","LU0310799852.SGD","BK4096","LU2125909759.SGD","IE00BMPRXR70.SGD","BK4209","MSTW","GASZ","TPYP","LU0266013472.USD","WNTR","LU0109394709.USD","LU1244550577.SGD","LU0511384066.AUD","LU1621768206.USD","LU0823434583.USD","IE00BMG7P587.USD","LU0302445910.USD","IGV","MLPI","FINX","LU2362541273.HKD","WCBR","LU0823434740.USD","LU1989764748.USD","STBQ","SMI3.UK","LU0788109394.HKD","BK4554","LU0566484027.USD","LU1261432733.SGD","LU0823421416.USD","LU1236620834.HKD","CIBR","IE00B29SXK94.USD","IE00BQXX3F31.USD","LU0345780950.USD","LU2065732104.USD","BK4212","CLOD","LU1074936037.SGD","LU2242652126.USD","LU0289961442.SGD","LU1894683264.USD","LU0289739343.SGD","TBXU","LU1917777945.USD","LU0719512351.SGD","WCLD","LU2237443465.HKD","IBB","MSTU","LU0198837287.USD","LU0128525689.USD","BK4580","IE00B64QTZ34.USD","LU0312595415.SGD","LU0170899867.USD","LU2384288077.EUR","LU1861214812.USD","LU2125909916.SGD","LU2211815571.USD","LU2238339852.HKD","LU2089283258.USD","LMI3.UK","LU0158827948.USD","BK4097","LU1935043536.SGD","LU0345770993.USD","BK4516","LU0642271901.SGD","LU2237443978.SGD","LU2106854487.HKD","SNEX","LU0154245756.USD","MSDD","LU0234570918.USD","BK4144","BK4561","09799","LU1061106388.HKD","MSTY.UK","LU1621767737.EUR","LU1712237335.SGD","IE0034235188.USD","PJP","LU0057025933.USD","CRPT","BK4566","LU2360107671.USD","BK4581","LU1023059063.AUD","OWNB","3SMI.UK","BIB","LU2023250843.SGD","LU0122376428.USD","EIX","BRBR","IE00BMG7P819.SGD","BK4597","IE00BQXX3D17.EUR","3LMI.UK","LU0211327993.USD","IE0002270589.USD","USAI","PSWD","PBE","LU0889565916.HKD","LU1236620750.USD","LU0314104364.USD","IE00BJT1NW94.SGD","LU1571399168.USD","BK4596","BBH","LU1674673691.USD","IE00B19Z9505.USD","LU2242646821.SGD","IE00BFXG0V08.USD","FXN","09399","LOW","BK4595","LU0081259029.USD","LU2286300806.USD","IBBQ","LU1316542783.SGD","LU2265009873.SGD","LU1935042991.SGD","LU0823421333.USD","APED","IE00BJJMRZ35.SGD","IE00BMQBXF63.USD","LU2275660780.HKD","LU1935043023.USD","LU0757428866.USD","AIFD","BK4560","BK4550","LU2023250504.SGD","LU2112291526.USD","TPZ","LU1861220033.SGD","LU0122379950.USD","BK4504","SG9999001440.SGD","BK4129","BK4227","LU1935042215.USD","LU1548497426.USD","LU2237443895.HKD","LU2357305700.SGD","LU0345770308.USD","LU2089984988.USD","LU2089284900.SGD","PANW","HOG","LU2244417387.USD","JJSF","LU1559883803.SGD","BK4114","IHAK","LU0689626769.HKD","IE00B19Z3581.USD","ESLT","LU0082616367.USD","IPAY","LU1244550221.USD","FXU","ACM","LU1878469433.USD","MSTZ","LU0742534661.SGD","SG9999014021.USD","MSTX","IE00B4R5TH58.HKD","BITQ","BK4081","LU0345781412.USD","LU1983299246.USD","LU1861217088.USD","OTLK","BK4588","LU0097036916.USD","IE00BZ18W340.USD","LU0069063385.USD","PALU","LU1057294990.SGD","BK4155","LU0048573561.USD","LU0289739699.SGD","LU0154245673.USD","EINC","BK4598","LU1974910355.USD","BK4091","LU1506573853.SGD","LU0106831901.USD","BK4011","HAKY","LU0053671581.USD","LU2133065610.SGD","IE00BSNM7G36.USD","IE00B19Z8W00.USD","MSTR","LU0052756011.USD","PYPL","LU1815336091.USD","BK4535","LU1169590202.USD","LU1861220207.SGD","MSTP","LU0320765992.SGD","BK4139","TXRH","LU2210150020.SGD","LU2237443622.USD","LU2211817866.USD","BK4196","IE00BKVL7J92.USD","BK4527","MST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684917529","title":"更正-更新版 2-美國食品藥品監督管理局(FDA)批准Regeneron公司用於治療全身性重症肌無力的藥物(11月18日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2684917529","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684917529?lang=zh_tw&edition=fundamental","pubTime":"2026-11-19 07:30","pubTimestamp":1795044608,"startTime":"0","endTime":"0","summary":"Regeneron表示,Livsayis需每三个月进行一次皮下注射。此次获批使Regeneron得以进入不断增长的全身性重症肌无力治疗市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261118:nL3T46Z21J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU0575583348.USD","LU1003077747.HKD","LU2539964713.USD","LU2089984988.USD","IE0034235188.USD","LU1153585028.USD","LU1989772840.SGD","LU0545039389.USD","LU1273509221.SGD","LU0823434583.USD","LU0171293334.USD","SG9999013999.USD","AZN.UK","LU2237443549.SGD","LU0708994859.HKD","03165","LU1481600234.SGD","LU2237443895.HKD","IE0002141913.USD","LU0047473722.EUR","BBH","TBXU","IE0009355771.USD","IBBQ","LU2433249047.HKD","LU2293690249.USD","LU0661504455.SGD","REGN","LU0211328371.USD","LU0997586515.USD","LU1003076772.USD","LU0957799991.USD","LU0882574055.USD","LU1064927863.SGD","IE00BFTCPJ56.SGD","IBB","BK4139","LU1104425308.USD","LU1267930573.SGD","LU0969580561.USD","LU0203347892.USD","LU1355424745.HKD","LU1496350171.SGD","LU2237443978.SGD","LU0960981461.USD","LU0128525689.USD","LU0949170772.SGD","LU0058720904.USD","LU0345777147.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684917522","title":"更正-更新版 2-美國食品藥品監督管理局(FDA)批准Regeneron公司用於治療全身性重症肌無力的藥物(11月18日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2684917522","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684917522?lang=zh_tw&edition=fundamental","pubTime":"2026-11-19 07:30","pubTimestamp":1795044608,"startTime":"0","endTime":"0","summary":"Regeneron表示,Livsayis需每三个月进行一次皮下注射。此次获批使Regeneron得以进入不断增长的全身性重症肌无力治疗市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261118:nL3S46Z21J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345777147.USD","LU1355424745.HKD","03165","LU0203347892.USD","LU1496350171.SGD","LU2237443978.SGD","IE0034235188.USD","LU0960981461.USD","SG9999013999.USD","LU1481600234.SGD","BBH","LU0949170772.SGD","LU2539964713.USD","LU2237443549.SGD","LU0823434583.USD","LU1153585028.USD","LU1989772840.SGD","IE00BFTCPJ56.SGD","LU0047473722.EUR","LU0661504455.SGD","LU0128525689.USD","LU1104425308.USD","LU0969580561.USD","LU0957799991.USD","LU2293690249.USD","LU2433249047.HKD","TBXU","LU0708994859.HKD","AZN.UK","LU2237443895.HKD","LU1273509221.SGD","LU0545039389.USD","REGN","LU2362541513.USD","LU1267930573.SGD","LU1003076772.USD","BK4139","LU0882574055.USD","LU0058720904.USD","LU2089984988.USD","LU0211328371.USD","LU0171293334.USD","LU1064927863.SGD","IE0002141913.USD","LU0997586515.USD","LU0575583348.USD","IBB","LU1003077747.HKD","IE0009355771.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684919586","title":"美國食品藥品監督管理局批准賽諾菲的一款遺傳性疾病藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2684919586","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684919586?lang=zh_tw&edition=fundamental","pubTime":"2026-11-19 04:45","pubTimestamp":1795034745,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局批准赛诺菲的一款遗传性疾病药物路透社11月18日-美国食品药品监督管理局(FDA)周三批准了赛诺菲的SASY.PA口服药物文格卢斯塔特(venglustat),该监管机构表示,这使其成为首款用于治疗一种影响大脑和神经系统的罕见遗传性疾病的药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261118:nL3S46Z1RZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU1917777945.USD","LU1974910355.USD","LU2089984988.USD","LU0289739699.SGD","LU2324357040.USD","LU2023250504.SGD","LU0882574055.USD","LU0823416689.USD","TBXU","LU2362541273.HKD","LU0823434740.USD","BBH","LU0114720955.EUR","LU0053666078.USD","LU2362541513.USD","BK4588","BK4139","REGN","LU0320765992.SGD","LU0889565916.HKD","LU0058720904.USD","LU0109394709.USD","IBB","LU2237438978.USD","BK4585","LU2106854487.HKD","LU0823434583.USD","LU2362540622.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684295999","title":"Biocon的帕妥珠單抗獲歐盟上市許可,成為EMA新「定製化臨床方法」下首個獲批的生物類似藥。","url":"https://stock-news.laohu8.com/highlight/detail?id=2684295999","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684295999?lang=zh_tw&edition=fundamental","pubTime":"2026-11-18 21:35","pubTimestamp":1795008931,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PPH","LU1992135472.HKD","IPOS","LU1992135399.USD","LU2322448791.USD","LU2272731600.USD","LU2272731865.HKD","LU2322448957.HKD","IBB","LU2473716301.USD","LU2272731782.SGD","IE00B5TLWC47.USD","BK4585","XPH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684967095","title":"一年多兩度終止,亞寶藥業創新藥研發頻遇挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2684967095","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684967095?lang=zh_tw&edition=fundamental","pubTime":"2026-11-18 18:28","pubTimestamp":1794997736,"startTime":"0","endTime":"0","summary":"亚宝药业(600351)近日披露的一则研发项目终止临床试验并计提减值准备的公告,让投资者猝不及防。回溯过往,这已经是近一年多以来,亚宝药业在创新药研发方面的第二次失利。11月13日晚间,亚宝药业披露公告称,公司决定终止SY-005注射液用于脓毒症适应症项目的临床研究开发工作。据悉,SY-005注射液为一种创新型的重组蛋白,是亚宝药业在创新药研发领域的重点布局之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202611183934096790.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202611183934096790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["GDOC","PBE","APXH","GSKH","XLVI","BK0239","600351","BK0096","BBP","BK4588","IBB","WRND","BK4585","LFSC","SBIO","BK0201","BK0077","BIOY","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104835039","title":"Genomics Ltd.宣佈延長與福泰製藥的戰略藥物發現合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1104835039","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104835039?lang=zh_tw&edition=fundamental","pubTime":"2026-11-18 17:45","pubTimestamp":1794995109,"startTime":"0","endTime":"0","summary":"Genomics Ltd.宣布延长与福泰制药的战略药物发现合作","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU1093756168.USD","LU1430594728.SGD","LU1069344957.HKD","LU2417539215.USD","LU0256863811.USD","IE00BZ9MQY76.HKD","IE00BJT1NW94.SGD","LU2324357040.USD","LU0432979614.USD","LU2362541273.HKD","LU2462157665.USD","LU2468319806.SGD","BK4567","SG9999013999.USD","LU0320765992.SGD","BBH","IE00B4R5TH58.HKD","BK4139","LU0234570918.USD","IDNA","LU2237438978.USD","IBBQ","IE0002141913.USD","LU1674673691.USD","IE00B2B36J28.USD","PBE","LU0079474960.USD","GNMX","LU0289739699.SGD","IE00B19Z9P08.USD","TBXU","BK4585","LU2236285917.USD","IBB","SG9999001176.SGD","BK4533","IE00B894F039.SGD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","SG9999001176.USD","LU2362540622.SGD","BIB","LU2362541513.USD","LU1093756325.SGD","BK4588","IE00BJJMRZ35.SGD","LU0058720904.USD","VRTX","LU1585245621.USD","LU1674673428.USD","LU0889565916.HKD","LU1778281490.HKD","LU0417517546.SGD","IE0002270589.USD","LU2456880835.USD","IE0009355771.USD","LU1035775433.USD","LU2089984988.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU0109394709.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684598249","title":"吉利德科學:首席企業事務官Johanna Mercier行權並減持2.8萬股,套現約477.55萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684598249","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684598249?lang=zh_tw&edition=fundamental","pubTime":"2026-11-18 11:06","pubTimestamp":1794971160,"startTime":"0","endTime":"0","summary":"21财经11月18日电,吉利德科学(GileadSciences,Inc.,纳斯达克:GILD)首席企业事务官JohannaMercier提交Form4持股变动声明。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611183933848425.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611183933848425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1037948541.HKD","SG9999015952.SGD","LU0965509101.SGD","LU1236620750.USD","BK4566","LU1674673428.USD","MEDI","GILD","LU2324357040.USD","LU1430594728.SGD","LU1934455277.USD","IE00BSNM7G36.USD","BIB","BK4568","LU2065170008.USD","LU1236620834.HKD","LU1934455863.HKD","LU0122379950.USD","IE00B19Z3B42.SGD","TBXU","BBH","LU1571399168.USD","LU0114720955.EUR","BK4550","TMED","LU0965509283.SGD","LU1066053197.SGD","BK4588","LU1674673691.USD","IE00B19Z3581.USD","LU1037948897.HKD","SG9999015978.USD","BK4583","BK4139","LU1023059063.AUD","BK4578","LU2087621335.USD","LU0109394709.USD","LU0859254822.USD","BMED","IBB","IE0002270589.USD","IE00BZ1G4Q59.USD","BK4585","LU1934455194.USD","LU2065169927.USD","LU2065171311.SGD","LU1061106388.HKD","LU1778281490.HKD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166977742","title":"再生元製藥:Libtayo新給藥方案獲批,初始12周每3周350毫克後改為每6周700毫克","url":"https://stock-news.laohu8.com/highlight/detail?id=1166977742","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166977742?lang=zh_tw&edition=fundamental","pubTime":"2026-11-17 20:03","pubTimestamp":1794916988,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布,Libtayo获批新用药方案:在初始12周每3周给予350毫克之后,可改为每6周给药700毫克。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU0109394709.USD","LU2362540622.SGD","IBB","LU2468319806.SGD","LU0058720904.USD","REGN","BK4588","BBH","LU0823416689.USD","IBBQ","LU0289739699.SGD","LU0320765992.SGD","LU2324357040.USD","LU2023250504.SGD","LU1974910355.USD","LU2106854487.HKD","LU1917777945.USD","TBXU","LU0889565916.HKD","LU0823434583.USD","LU0823434740.USD","LU0053666078.USD","LU2237438978.USD","LU0114720955.EUR","BK4585","LU2362541273.HKD","LU0882574055.USD","BK4139","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173398938","title":"再生元製藥:Libtayo給藥方案補充生物製品許可申請在美接受審查,預計2027年3月獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=1173398938","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173398938?lang=zh_tw&edition=fundamental","pubTime":"2026-11-17 20:02","pubTimestamp":1794916931,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布,其Libtayo给药方案的补充生物制品许可申请(sBLA)已在美国进入审查阶段。该申请若获批准,将为Libtayo的用药方式提供新的选择。公司方面预计,相关决定将于2027年3月出炉。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","LU2089984988.USD","LU0823434740.USD","BK4139","LU0882574055.USD","LU0889565916.HKD","REGN","LU0289739699.SGD","IBB","LU1917777945.USD","LU1974910355.USD","LU0823434583.USD","LU0053666078.USD","LU2362540622.SGD","LU2023250504.SGD","LU0058720904.USD","LU0114720955.EUR","LU0823416689.USD","BK4588","LU0320765992.SGD","LU2362541513.USD","BBH","LU2324357040.USD","TBXU","LU2106854487.HKD","LU2362541273.HKD","LU0109394709.USD","BK4585","IBBQ","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111317149","title":"Libtayo®(西米普利單抗)獲歐盟批准:皮膚癌、肺癌及宮頸癌適應症可實現延長給藥與更快輸注","url":"https://stock-news.laohu8.com/highlight/detail?id=1111317149","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111317149?lang=zh_tw&edition=fundamental","pubTime":"2026-11-17 20:01","pubTimestamp":1794916908,"startTime":"0","endTime":"0","summary":"Libtayo®(西米普利单抗)获欧盟批准:皮肤癌、肺癌及宫颈癌适应症可实现延长给药与更快输注","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0289739699.SGD","LU2362541513.USD","LU0114720955.EUR","BK4588","LU1917777945.USD","LU2089984988.USD","LU2106854487.HKD","LU0882574055.USD","LU2468319806.SGD","IBBQ","LU0889565916.HKD","BBH","LU0109394709.USD","LU2324357040.USD","LU2362540622.SGD","LU2023250504.SGD","LU0058720904.USD","IBB","REGN","TBXU","LU0053666078.USD","LU0823434740.USD","BK4585","LU0320765992.SGD","LU2362541273.HKD","LU2237438978.USD","LU0823434583.USD","LU0823416689.USD","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684667142","title":"巴克萊上調安進目標價至430美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684667142","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684667142?lang=zh_tw&edition=fundamental","pubTime":"2026-11-17 14:47","pubTimestamp":1794898033,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BIB","LU2468319806.SGD","LU0122379950.USD","LU1061106388.HKD","LU2089984988.USD","BK4599","BK4585","IE00BJJMRZ35.SGD","UUP","IE00B2B36J28.USD","SG9999001440.SGD","BK4566","UDN","IE0002141913.USD","IE00BJT1NW94.SGD","AMGN","IBBQ","BK4588","LU0889565916.HKD","IBB","LU2112291526.USD","BBH","IE00B4R5TH58.HKD","IE0009355771.USD","LU1571399168.USD","LU0109394709.USD","LU0868494617.USD","LU0289739699.SGD","BK4534","TBXU","LU1023059063.AUD","LU2242646821.SGD","LU0058720904.USD","LU2242652126.USD","BK4139","LU1983299246.USD","LU1236620750.USD","LU1236620834.HKD","BK4581","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0320765992.SGD","PJP","BK4533","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684623045","title":"吉利德就一款試驗性埃博拉藥物簽署了仿製藥許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2684623045","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684623045?lang=zh_tw&edition=fundamental","pubTime":"2026-11-17 06:06","pubTimestamp":1794866767,"startTime":"0","endTime":"0","summary":"吉利德就一款试验性埃博拉药物签署了仿制药许可协议路透社11月16日-吉利德科学公司周一表示,已与三家仿制药生产商签署了免版税协议,如果其试验性埃博拉预防药物在临床试验中取得成功并获得监管批准,该药物将在127个主要为低收入和下中收入的国家上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261116:nL3T46X1NV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","BIB","SG9999015945.SGD","IE00B19Z3581.USD","LU1934455277.USD","LU2324357040.USD","TMED","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU1585245621.USD","LU1037948541.HKD","IE00BSNM7G36.USD","LU1057294990.SGD","BK4583","LU2065171402.SGD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","GILD","LU1023059063.AUD","LU0058720904.USD","LU0320765992.SGD","SG9999015978.USD","BK4566","LU1934455194.USD","BK4578","IE00B19Z3B42.SGD","BBH","IBB","LU0882574055.USD","TBXU","LU0859254822.USD","BK4588","LU0965509101.SGD","LU1037948897.HKD","LU1236620750.USD","LU2112291526.USD","LU0122379950.USD","LU0114720955.EUR","LU2089984988.USD","LU0109394709.USD","BK4585","LU0965508806.USD","LU1674673428.USD","LU1934455863.HKD","LU0289739699.SGD","LU2468319806.SGD","BMED","IBBQ","LU0965509283.SGD","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176147566","title":"吉利德:相關協議覆蓋127箇中低收入國家,涵蓋所有出現埃博拉病毒病例的非洲國家","url":"https://stock-news.laohu8.com/highlight/detail?id=1176147566","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176147566?lang=zh_tw&edition=fundamental","pubTime":"2026-11-17 05:10","pubTimestamp":1794863458,"startTime":"0","endTime":"0","summary":"吉利德科学:上述协议覆盖127个中低收入国家,其中包括所有已出现埃博拉病毒病例的非洲国家。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","LU2087621335.USD","LU2468319806.SGD","LU1236620834.HKD","LU1430594728.SGD","BK4583","IE00B19Z3581.USD","IE0002270589.USD","LU0289739699.SGD","BK4550","LU1037948541.HKD","LU1839511570.USD","SG9999015945.SGD","BBH","BK4532","GILD","BK4568","LU1571399168.USD","MEDI","IE00BKVL7J92.USD","LU0861579265.USD","BK4139","LU0122379950.USD","TMED","LU2065170008.USD","BK4566","BK4585","BIB","LU1778281490.HKD","LU2357627491.SGD","SG9999015986.USD","LU0320765992.SGD","LU1023059063.AUD","LU0058720904.USD","LU1057294990.SGD","LU1066051498.USD","LU2065169927.USD","SG9999015978.USD","LU1066053197.SGD","LU0965509101.SGD","LU1061106388.HKD","LU0859254822.USD","LU1674673691.USD","LU2324357040.USD","BK4588","LU0882574055.USD","LU1674673428.USD","LU1934455194.USD","LU0965509010.AUD","IE00BSNM7G36.USD","LU2065171311.SGD","IE00B7SZLL34.SGD","BMED","BK4578","LU0965508806.USD","LU1037948897.HKD","LU1236620750.USD","LU1934455277.USD","LU2112291526.USD","LU0109394709.USD","LU0823416689.USD","LU0114720955.EUR","LU2065171402.SGD","IBB","IBBQ","LU1934455863.HKD","TBXU","LU1585245621.USD","IE00B3T34201.USD","LU2089984988.USD","SG9999015952.SGD","LU0889565916.HKD","IE00BZ1G4Q59.USD","LU0234570918.USD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195103583","title":"吉利德科學攜手Dr. Reddy’s、Eva Pharma及Ferozsons Laboratories達成自願許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1195103583","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195103583?lang=zh_tw&edition=fundamental","pubTime":"2026-11-17 05:07","pubTimestamp":1794863274,"startTime":"0","endTime":"0","summary":"吉利德科学(Gilead Sciences)宣布,已与Dr. Reddy’s、Eva Pharma以及Ferozsons Laboratories签署自愿许可协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","BIB","BK4583","LU1057294990.SGD","LU1066051498.USD","IE0002270589.USD","LU0965509101.SGD","LU1066053197.SGD","LU1778281490.HKD","LU1037948897.HKD","LU0234570918.USD","LU2065171402.SGD","LU1674673691.USD","LU1571399168.USD","LU2324357040.USD","LU1934455277.USD","LU0122379950.USD","IE00B3T34201.USD","LU1037948541.HKD","BK4588","LU1934455194.USD","LU1023059063.AUD","LU2087621335.USD","LU0861579265.USD","LU0965508806.USD","LU0882574055.USD","SG9999015945.SGD","BK4532","LU0889565916.HKD","SG9999015978.USD","BK4578","LU0859254822.USD","IE00B19Z3B42.SGD","TBXU","LU0058720904.USD","LU1674673428.USD","LU2065171311.SGD","MEDI","LU0965509283.SGD","IE00B7SZLL34.SGD","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU1585245621.USD","LU0320765992.SGD","GILD","IE00B19Z3581.USD","LU1236620834.HKD","IE00BKVL7J92.USD","LU1934455863.HKD","LU2065170008.USD","LU2089984988.USD","LU0289739699.SGD","LU2112291526.USD","LU2357627491.SGD","LU2468319806.SGD","BK4585","LU1061106388.HKD","LU1236620750.USD","IE00BSNM7G36.USD","LU1839511570.USD","SG9999015986.USD","LU0823416689.USD","BK4139","LU0965509010.AUD","BMED","BBH","BK4568","IBBQ","BK4566","LU0109394709.USD","LU0114720955.EUR","LU2065169927.USD","TMED","LU1430594728.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196230043","title":"吉利德科學通過自願許可擴大在研藥物Obeldesivir用於本迪布焦型埃博拉病毒病的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1196230043","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196230043?lang=zh_tw&edition=fundamental","pubTime":"2026-11-17 05:06","pubTimestamp":1794863175,"startTime":"0","endTime":"0","summary":"吉利德科学通过自愿许可扩大在研药物Obeldesivir用于本迪布焦型埃博拉病毒病的可及性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU1066053197.SGD","TMED","LU0861579265.USD","BK4568","LU0882574055.USD","TBXU","LU0234570918.USD","IE00B3T34201.USD","LU1037948541.HKD","LU1839511570.USD","IE00B19Z3581.USD","LU1934455277.USD","IBB","SG9999015986.USD","LU0823416689.USD","GILD","LU1061106388.HKD","BK4139","LU1585245621.USD","SG9999015952.SGD","BK4578","IE00BKVL7J92.USD","LU0965509010.AUD","LU1934455194.USD","LU1934455863.HKD","BK4532","IE00BSNM7G36.USD","LU0965509283.SGD","SG9999015978.USD","LU0889565916.HKD","BK4583","LU2089984988.USD","LU1674673691.USD","LU1037948897.HKD","LU2065170008.USD","IE00B7SZLL34.SGD","IE0002270589.USD","LU1571399168.USD","LU0109394709.USD","BK4585","LU1236620750.USD","LU1057294990.SGD","BBH","BIB","LU2065171311.SGD","LU2357627491.SGD","LU2112291526.USD","BMED","LU2468319806.SGD","LU1236620834.HKD","LU1674673428.USD","LU1066051498.USD","LU0058720904.USD","LU0122379950.USD","LU0289739699.SGD","LU0965509101.SGD","BK4566","LU0859254822.USD","BK4588","IE00B19Z3B42.SGD","LU0965508806.USD","LU1023059063.AUD","LU1430594728.SGD","LU2065169927.USD","IBBQ","LU2324357040.USD","LU2065171402.SGD","MEDI","SG9999015945.SGD","BK4550","IE00BZ1G4Q59.USD","LU2087621335.USD","LU1778281490.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683780575","title":"英硅智能(03696.HK)與羅欣藥業(002793.SZ)達成 AI 製藥戰略合作,聚焦消化與代謝等慢性病創新藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2683780575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683780575?lang=zh_tw&edition=fundamental","pubTime":"2026-11-13 16:32","pubTimestamp":1794558763,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WRND","ARTY","APXH","XLVI","QTOC","LFSC","BK4588","SBIO","BBP","PBE","CHAT","BIOY","AIPO","GDOC","BK4585","AGIX","VTHR","GSKH","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}